Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction With a Single-dose Dexmedetomidine — D-pofol

Igel Clinical Trial

Official title:
Preducted Effect-site Concentration of Propofol for I-gel Insertion During Anesthesia Induction

Status Completed

Clinical Trial Summary

Clinical Trial Description

Before anethetic induction, infuse dexmedetomidine 0.5 mcg/kg for 2 minutes and after injection of lidocaine 30 mg, propofol infusion by using target controlled infusion (TCI) pump. Effect site concentraion of propofol start from 5 and changes the concentration as previous response to i-gel insertion as up and down methods. Failure of previous subjects are defined as difficulty to mouth open, severe nausea and couph and laryngeal spasm, and not loss of consciousness. ;

Study Design

Related Conditions & MeSH terms

Igel

Clinical Trial Details

NCT number	NCT02268656
Study type	Interventional
Source	Gachon University Gil Medical Center
Contact
Status	Completed
Phase	N/A
Start date	October 2014
Completion date	February 2015

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT05028023` - Tracheal Dilatation in Pediatric Patients With Acquired Tracheal Stenosis, and the Effects of Apneic Oxygenation	N/A
	Completed	`NCT05545163` - Comparison of Simulated Standard Versus Modified Jaw Thrust I-gel Insertion Technique in Novice Anesthesiologists	N/A